Simone Courvoisier was a French experimental pharmacologist who, while the head of pharmacology at Rhône-Poulenc in the 1950s, investigated the use of the antipsychotic medication chlorpromazine.[1][2] She discovered that the compound promazine had sedating properties despite not being an antihistamine like its precursor promethazine, and then extensively analyzed the properties of its descendant drug chlorpromazine.[3][4]

References

edit
  1. ^ "Paul Charpentier, Henri-Marie Laborit, Simone Courvoisier, Jean Delay, and Pierre Deniker". Science History Institute. Retrieved 2024-11-09.
  2. ^ Ban, Thomas A. (August 2007). "Fifty years chlorpromazine: a historical perspective". Neuropsychiatric Disease and Treatment. 3 (4): 495–500. PMC 2655089. PMID 19300578.
  3. ^ Sneader, Walter (2002). "History of Drug Therapy. The 50th Anniversary of Chlorpromazine". Drug News and Perspectives. doi:10.1358/dnp.2002.15.7.840082.
  4. ^ Cookson, John (July 2019). "Histamine in psychiatry: promethazine as a sedative anticholinergic". BJPsych Advances. 25 (4): 265–268. doi:10.1192/bja.2019.21. ISSN 2056-4678.